Press Releases

Media Inquiries - media@caredx.com

Date	Title and Summary	Additional Formats
Toggle Summary Apr 22, 2021	Palmetto MolDx Issues Foundational Coverage for Molecular Testing in Solid Organ Allograft Rejection Current Medicare coverage for CareDx services remains unchanged under the new universal coverage policy SOUTH SAN FRANCISCO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of	View HTML
Toggle Summary Apr 22, 2021	CareDx to Debut Multicenter Data on AlloSure® Lung, an Analytically and Clinically Validated Biomarker of Graft Injury for Lung Transplant Patients Leading transplant clinicians to present data in seven abstracts at International Society of Heart and Lung Transplantation Annual Meeting SOUTH SAN FRANCISCO, Calif., April 22, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery,	View HTML
Toggle Summary Apr 21, 2021	CareDx to Report First Quarter 2021 Financial Results SOUTH SAN FRANCISCO, Calif., April 21, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML
Toggle Summary Apr 20, 2021	CareDx Showcases Transplantation Innovation and Leadership in Europe at EFI 2021 Virtual Events to Highlight New Data and AlloSeq Solutions for European Labs and Clinicians SOUTH SAN FRANCISCO, Calif., April 20, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically	View HTML
Toggle Summary Apr 16, 2021	CareDx to Present at UNOS Transplant Management Forum Company to showcase its latest integrated solutions for improving care across the whole transplant journey SOUTH SAN FRANCISCO, Calif., April 16, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization	View HTML
Toggle Summary Apr 08, 2021	CareDx Announces New HLA Typing Service Offering for Research Purposes Initial projects underway for global pharmaceutical company SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value	View HTML
Toggle Summary Apr 05, 2021	CareDx to Participate in National Kidney Foundation 2021 Spring Clinical Meetings CareDx to Host Virtual Exhibitor Showcase and Continuing Medical Education Program SOUTH SAN FRANCISCO, Calif., April 05, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically	View HTML
Toggle Summary Mar 31, 2021	CareDx Enhances Leadership Team with Key Appointments CareDx Builds for the Future by Investing in Talent SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare	View HTML
Toggle Summary Mar 23, 2021	CareDx Supports Vir Biotechnology’s Clinical Trial Recruitment Efforts for COMET-ICE Effort underscores CareDx’s commitment to the transplant community SOUTH SAN FRANCISCO, Calif., March 23, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value	View HTML
Toggle Summary Mar 17, 2021	CareDx Strengthens Bioinformatics Capabilities with Acquisition of BFS Molecular SOUTH SAN FRANCISCO, Calif., March 17, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today	View HTML